Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases
Related Posts
Shannon EM, Chen L, Yuan A, Chary A, Gabrielian S, Eisenman DP, Washington DL. Extreme Heat, Social Factors, and Mortality Among California Veterans With Cardiometabolic[...]
Blanco LR, Choi A, Hays RD. Differences in Retirement Knowledge and Financial Preparedness between Hispanic and Non-Hispanic White Older Adults in the United States. Gerontologist.[...]
Binod M, Chang L, Hung MW, Dong TS, Kilpatrick LA, Tomasevic A, Choy M, Shin A, Mayer EA, Church A. Multi-omics analysis reveal clinical-gut-brain interactions[...]